Best Open Access Articles On Juvenile Idiopathic Arthritis Treatment

 Juvenile idiopathic arthritis is a wide phrase that explains clinically heterogeneous group of arthritis of unknown cause, which starts before 16 years of age. This phrase encloses numerous disease categories, each of which has well defined presentation, clinical manifestations, and, genetic background, presumably and etiopathogenesis. However, none of the available drugs has curative potential, prognosis has greatly enhanced as a result of substantial progresses in disease management. The most principal new evolution has been the introduction of the biologic medications, which comprises a valuable treatment option for patients who are impenetrable to conventional antirheumatic agents. Further discernment into the disease pathogenesis and treatment will be produced by the continuous advances in understanding of the mechanisms related to the immune response and inflammatory process, and by the development of new drugs that are able of selectively inhibiting single molecules or pathways.